HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Nagy Selected Research

RC 121

9/2001Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.
9/2001Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
2/2000Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Nagy Research Topics

Disease

23Neoplasms (Cancer)
01/2005 - 02/2000
7Inflammation (Inflammations)
01/2015 - 03/2002
5Wounds and Injuries (Trauma)
01/2019 - 09/2001
4Hypersensitivity (Allergy)
06/2018 - 09/2001
4Neoplasm Metastasis (Metastasis)
10/2001 - 06/2000
4Carcinoma (Carcinomatosis)
09/2001 - 10/2000
3Human Influenza (Influenza)
08/2016 - 02/2013
3Necrosis
01/2015 - 03/2001
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2004 - 08/2000
3Glioblastoma (Glioblastoma Multiforme)
04/2002 - 02/2000
3Ovarian Neoplasms (Ovarian Cancer)
09/2001 - 10/2000
3Astrocytoma (Pilocytic Astrocytoma)
05/2001 - 11/2000
3Hypoxia (Hypoxemia)
04/2001 - 11/2000
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2001 - 10/2000
2Asthma (Bronchial Asthma)
06/2018 - 09/2001
2Hemorrhage
01/2015 - 04/2008
2Cholestasis
10/2012 - 03/2011
2Fibrosis (Cirrhosis)
10/2012 - 06/2011
2Pain (Aches)
09/2010 - 12/2001
2Body Weight (Weight, Body)
01/2006 - 09/2001
2Breast Neoplasms (Breast Cancer)
01/2001 - 10/2000
2Infections
01/2001 - 12/2000
2Edema (Dropsy)
01/2001 - 11/2000
2Prostatic Neoplasms (Prostate Cancer)
11/2000 - 10/2000
1COVID-19
12/2021
1Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
06/2018
1Exercise-Induced Asthma (Asthma, Exercise Induced)
06/2018
1Allergic Rhinitis
06/2018
1Bacterial Infections (Bacterial Infection)
12/2017
1Spinal Cord Injuries (Spinal Cord Injury)
03/2016
1Teratoma (Teratoid Tumor)
03/2016
1Shock
11/2015
1Burns
10/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2013
1Extrahepatic Cholestasis
03/2012

Drug/Important Bio-Agent (IBA)

12Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2005 - 02/2000
11Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2005 - 02/2000
10AN 204 (AN 201)IBA
01/2002 - 02/2000
7Doxorubicin (Adriamycin)FDA LinkGeneric
04/2002 - 02/2000
7Messenger RNA (mRNA)IBA
09/2001 - 02/2000
6Peptides (Polypeptides)IBA
08/2006 - 02/2000
6Somatostatin Receptors (Somatostatin Receptor)IBA
01/2005 - 06/2000
6BombesinIBA
01/2005 - 10/2000
6AN 238IBA
09/2001 - 02/2000
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2004 - 10/2000
4Epidermal Growth Factor (EGF)IBA
05/2004 - 08/2000
4AN 207IBA
01/2002 - 02/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2001 - 11/2000
3CytokinesIBA
06/2014 - 03/2002
3Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
05/2004 - 10/2000
3Histamine (Histamine Dihydrochloride)FDA Link
05/2003 - 05/2001
3lysine(6)-doxorubicin LHRHIBA
09/2001 - 08/2000
3LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2001 - 11/2000
3RC 121IBA
09/2001 - 02/2000
2VaccinesIBA
12/2017 - 02/2013
2Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2013 - 03/2002
2Proteins (Proteins, Gene)FDA Link
03/2012 - 01/2001
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2012 - 07/2006
2SolutionsIBA
09/2010 - 04/2004
2RadiopharmaceuticalsIBA
05/2007 - 01/2005
2LipopolysaccharidesIBA
07/2006 - 05/2001
2Cytotoxins (Cytolysins)IBA
01/2005 - 01/2001
2Gastrin-Releasing PeptideIBA
05/2004 - 04/2002
2AN 215IBA
04/2002 - 11/2000
2Chemokine CCL5IBA
02/2002 - 09/2001
2ChemokinesIBA
02/2002 - 09/2001
2Carboxylic Ester HydrolasesIBA
09/2001 - 11/2000
2Pharmaceutical PreparationsIBA
07/2001 - 08/2000
2Cyclin D1IBA
07/2001 - 01/2001
2Hormones (Hormone)IBA
07/2001 - 02/2000
2factor V LeidenIBA
01/2001 - 10/2000
2AndrogensIBA
11/2000 - 10/2000
2vapreotideIBA
10/2000 - 08/2000
2Estrogens (Estrogen)FDA Link
10/2000 - 02/2000
1AerosolsIBA
12/2021
1Ointments (Pastes)IBA
01/2019
1Petrolatum (Vaseline)FDA Link
01/2019
1GoldIBA
01/2019
1Immunoglobulin E (IgE)IBA
06/2018
1Hemagglutinins (Hemagglutinin)IBA
08/2016
1HydrogelsIBA
03/2016
1IonsIBA
11/2015
1Viral AntigensIBA
01/2015
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
11/2014
1CopperIBA
10/2014
1N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
02/2014
1C-Reactive ProteinIBA
10/2013
1Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2012
1Type II Tumor Necrosis Factor ReceptorsIBA
10/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2012
1Rosuvastatin Calcium (Crestor)FDA Link
10/2012
1ChitosanIBA
03/2012

Therapy/Procedure

11Therapeutics
01/2005 - 01/2000
10Drug Therapy (Chemotherapy)
01/2005 - 02/2000
5Injections
03/2016 - 02/2000
3Ligation
10/2012 - 03/2011
3Aftercare (After-Treatment)
11/2000 - 02/2000
1Surgical Instruments (Clip)
03/2016
1Compression Bandages
10/2014
1Critical Care (Surgical Intensive Care)
02/2013